Long-term survival may be possible in patients with advanced ovarian cancer complicated by malignant pericardial effusion and tamponade if systemic manifestations are controlled.
Answers are grounded in this paper and cite their sources.
May support individualized prognosis counseling in rare tamponade cases; leaves open prospective validation of survival predictors.
Malignant pericardial effusion and tamponade are rarely seen complications of epithelial ovarian cancer. With the use of multiagent chemotherapy these complications may be seen more frequently in the future. Therapy should be individualized, as long-term survival may be possible if the systemic manifestations of the cancer can be controlled.
No takes yet. Share an insight, caveat, or question.
Levitan et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: